Antimicrobial-resistant Shigella: where do we go next?

Shigella spp. that are resistant to almost all antimicrobial classes are increasing in prevalence and becoming globally dominant. The situation is critical and highlights a trend that is mirrored by other enteric bacterial pathogens. New interventions to prevent and treat these infections are essential to tackle a potential public health catastrophe.

Automated summary

Shigella spp. with high resistance to antimicrobial classes are rapidly increasing and becoming dominant worldwide. This critical situation mirrors a trend observed in other enteric bacterial pathogens. It is crucial to develop new interventions for the prevention and treatment of these infections in order to address a potential public health catastrophe.